Technische Universität Dresden

Combining Renormalized Singles GW Methods with the Bethe-Salpeter Equation for Accurate Neutral Excitation Energies (2022) Yang W, Li J, Golze D Journal article A Review on the Modeling of the Clinching Process Chain - Part III: Operational Phase (2022) Schramm B, Harzheim S, Weiß D, Joy TD, Hofmann M, Mergheim J, Wallmersperger T Journal article, Review article A sustainable green electron reactive processing for fire safety of polypropylene nanocomposites (2022) Xiao D, Zheng MT, Gohs U, Wagenknecht U, Voit B, Xiao XQ, Wang DY Journal article Tailoring surface properties, biocompatibility and corrosion behavior of stainless steel by laser induced periodic surface treatment towards developing biomimetic stents (2022) Saqib M, Beshchasna N, Pelaccia R, Roshchupkin A, Yanko I, Husak Y, Kyrylenko S, et al. Journal article Reusable and Antibacterial Polymer-Based Nanocomposites for the Adsorption of Dyes and the Visible-Light-Driven Photocatalytic Degradation of Antibiotics (2022) Wang J, Sgarzi M, Nemeckova Z, Henych J, Licciardello N, Cuniberti G Journal article Electronic and thermal signatures of phosphorene grain boundaries under uniaxial strain (2022) Mendez AR, Sandonas LM, Dianat A, Gutierrez R, Cuniberti G Journal article CFR-PEEK Pedicle Screw Instrumentation for Spinal Neoplasms: A Single Center Experience on Safety and Efficacy (2022) Joerger AK, Seitz S, Lange N, Aftahy AK, Wagner A, Ryang YM, Bernhardt D, et al. Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients (pts) with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant chemotherapy (NACT) (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al. Conference contribution